Twist Bioscience Corporation (TWST)

NMS – Цена в реальном времени. Валюта: USD

124.61

+1.49 (1.21%)

Рынок открыт: Aug 12, 2026, 12:37 PM EDT

123.08

-0.04 (-0.03%)

Предыдущая сессия: Aug 11, 2026, 7:54 PM EDT

Обзор
Новости
График
Финансы
Дивиденды
Прогноз
Владельцы
Профиль

Twist Bioscience Corporation (TWST)

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

Контакты

Мы в соцсетях

Twist Bioscience Corporation (TWST)

Artisan Global Discovery Fund Q2 2026 Portfolio Activity

Twist Biosciences: Accelerating Growth, Diminishing Margin Of Safety

Twist Bioscience Announces Pricing of Upsized $300.0 Million Public Offering of Common Stock

Twist Bioscience Announces Proposed Public Offering of $250.0 Million of Common Stock

Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

Twist Bioscience Corporation (TWST) Q3 2026 Earnings Call Transcript

Twist Bioscience Sees AI Drug Discovery Pipeline Expand

Видео

No Data

Пресс-релизы

Twist Bioscience Announces Pricing of Upsized $300.0 Million Public Offering of Common Stock

Twist Bioscience Announces Proposed Public Offering of $250.0 Million of Common Stock

Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

Twist Bioscience Announces Fiscal 2026 Third Quarter Financial Results

Search stocks

Twist Bioscience Corporation (TWST)

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

Контакты

Мы в соцсетях

Twist Bioscience Corporation (TWST)

Artisan Global Discovery Fund Q2 2026 Portfolio Activity

Twist Biosciences: Accelerating Growth, Diminishing Margin Of Safety

Twist Bioscience Announces Pricing of Upsized $300.0 Million Public Offering of Common Stock

Twist Bioscience Announces Proposed Public Offering of $250.0 Million of Common Stock

Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

Twist Bioscience Corporation (TWST) Q3 2026 Earnings Call Transcript

Twist Bioscience Sees AI Drug Discovery Pipeline Expand

Видео

No Data

Пресс-релизы

Twist Bioscience Announces Pricing of Upsized $300.0 Million Public Offering of Common Stock

Twist Bioscience Announces Proposed Public Offering of $250.0 Million of Common Stock

Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

Twist Bioscience Announces Fiscal 2026 Third Quarter Financial Results